A review of infectious complications after haploidentical hematopoietic stem cell transplantations (Q39247468)

10 September 2017

title

A review of infectious complications after haploidentical hematopoietic stem cell transplantations (English)

1 reference

10 September 2017

Erden Atilla

1

1 reference

10 September 2017

Pinar Ataca Atilla

series ordinal

2

1 reference

10 September 2017

Sinem Civriz Bozdağ

series ordinal

3

1 reference

10 September 2017

Taner Demirer

series ordinal

4

1 reference

10 September 2017

publication date

17 April 2017

1 reference

10 September 2017

1 reference

10 September 2017

volume

45

1 reference

10 September 2017

issue

4

1 reference

10 September 2017

page(s)

403-411

1 reference

Secondary acute leukemia following mitoxantrone-based high-dose chemotherapy for primary breast cancer patients

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S15010-017-1016-1

Salvage high-dose chemotherapy for children with extragonadal germ-cell tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-017-1016-1

Autologous hematopoietic stem cell transplantation for breast cancer in Europe: critical evaluation of data from the European Group for Blood and Marrow Transplantation (EBMT) Registry 1990-1999.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-017-1016-1

High dose chemotherapy with autologous hematopoietic stem cell support for solid tumors other than breast cancer in adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-017-1016-1

High-Dose Chemotherapy With Autologous Hematopoietic Stem-Cell Transplantation in Metastatic Breast Cancer: Overview of Six Randomized Trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-017-1016-1

High-dose busulfan, melphalan and thiotepa followed by autologous peripheral blood stem cell (PBSC) rescue in patients with advanced stage III/IV ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-017-1016-1

Haploidentical hematopoietic stem cell transplantation: state of art.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-017-1016-1

Prognostic factors for survival in patients with advanced renal cell carcinoma undergoing nonmyeloablative allogeneic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-017-1016-1

Autoimmune thrombocytopenia in a patient with small cell lung cancer developing after chemotherapy and resolving following autologous peripheral blood stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-017-1016-1

Reduced-intensity allogeneic hematopoietic stem cell transplantation in metastatic colorectal cancer as a novel adoptive cell therapy approach. The European group for blood and marrow transplantation experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-017-1016-1

Unmanipulated haploidentical transplants compared with other alternative donors and matched sibling grafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-017-1016-1

Comparison of Outcomes of Hematopoietic Cell Transplants from T-Replete Haploidentical Donors Using Post-Transplantation Cyclophosphamide with 10 of 10 HLA-A, -B, -C, -DRB1, and -DQB1 Allele-Matched Unrelated Donors and HLA-Identical Sibling Donors:

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-017-1016-1

Unmanipulated haploidentical versus matched unrelated donor allogeneic stem cell transplantation in adult patients with acute myelogenous leukemia in first remission: a retrospective pair-matched comparative study of the Beijing approach with the EB

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-017-1016-1

Early lymphocyte recovery predicts superior overall survival after unmanipulated haploidentical blood and marrow transplant for myelodysplastic syndrome and acute myeloid leukemia evolving from myelodysplastic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-017-1016-1

Lymphocyte Recovery Predicts Outcomes in Cord Blood and T Cell–Depleted Haploidentical Stem Cell Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-017-1016-1

Immune reconstitution after haploidentical hematopoietic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-017-1016-1

Effects of the NK cell recovery on outcomes of unmanipulated haploidentical blood and marrow transplantation for patients with hematologic malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-017-1016-1

Haploidentical stem cell transplantation in leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-017-1016-1

Infections after T-replete haploidentical transplantation and high-dose cyclophosphamide as graft-versus-host disease prophylaxis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-017-1016-1

The First European Conference on Infections in Leukaemia - ECIL1: a current perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-017-1016-1

Infections after Transplantation of Bone Marrow or Peripheral Blood Stem Cells from Unrelated Donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-017-1016-1

Antibiotic prophylaxis with meropenem after allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-017-1016-1

Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-017-1016-1

Metagenomic analysis of the stool microbiome in patients receiving allogeneic stem cell transplantation: loss of diversity is associated with use of systemic antibiotics and more pronounced in gastrointestinal graft-versus-host disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-017-1016-1

Guideline for the management of fever and neutropenia in children with cancer and/or undergoing hematopoietic stem-cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-017-1016-1

Neutrophil function after bone marrow and hematopoietic stem cell transplant

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-017-1016-1

Systematic Nutritional Support in Allogeneic Hematopoietic Stem Cell Transplant Recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-017-1016-1

How do I manage hyperglycemia/post-transplant diabetes mellitus after allogeneic HSCT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-017-1016-1

Allogeneic hematopoietic cell transplantation for metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-017-1016-1

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: V. The 2014 Ancillary Therapy and Supportive Care Working Group Report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-017-1016-1

Challenges to Preventing Infectious Complications, Decreasing Re-hospitalizations, and Reducing Cost Burden in Long-Term Survivors After Allogeneic Hematopoietic Stem Cell Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-017-1016-1

Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-017-1016-1

Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-017-1016-1

Incidence and outcome of invasive fungal diseases after allogeneic stem cell transplantation: a prospective study of the Gruppo Italiano Trapianto Midollo Osseo (GITMO).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-017-1016-1

Consensus guidelines for antifungal prophylaxis in haematological malignancy and haemopoietic stem cell transplantation, 2014.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-017-1016-1

An overview of infectious complications after allogeneic hematopoietic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-017-1016-1

Risk factors for invasive fungal disease after allogeneic hematopoietic stem cell transplantation: a single center experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-017-1016-1

Disseminated Fusariosis in Immunocompromised Children-Analysis of Recent Cases Identified in the Global Fungiscope Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-017-1016-1

Systemic antifungal prophylaxis after hematopoietic stem cell transplantation: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-017-1016-1

Systematic review and mixed treatment comparison meta-analysis of randomized clinical trials of primary oral antifungal prophylaxis in allogeneic hematopoietic cell transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-017-1016-1

Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or allogeneic haemopoietic stem-cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-017-1016-1

Virus infection in HLA-haploidentical hematopoietic stem cell transplantation: incidence in the context of immune recovery in two different transplantation settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-017-1016-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-017-1016-1

Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplants is the complex result of BK virus infection, preparative regimen intensity and donor type

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-017-1016-1

Improved early outcomes using a T cell replete graft compared with T cell depleted haploidentical hematopoietic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-017-1016-1

Management strategies for cytomegalovirus infection and disease in solid organ transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-017-1016-1

Efficacy of a viral load-based, risk-adapted, preemptive treatment strategy for prevention of cytomegalovirus disease after hematopoietic cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-017-1016-1

Acyclovir prophylaxis against herpes simplex virus infection in patients with leukemia. A randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-017-1016-1

Acyclovir prophylaxis of herpes-simplex-virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-017-1016-1

Valganciclovir for the prevention of complications of late cytomegalovirus infection after allogeneic hematopoietic cell transplantation: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-017-1016-1

How I treat adenovirus in hematopoietic stem cell transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-017-1016-1

Durable engraftment of major histocompatibility complex-incompatible cells after nonmyeloablative conditioning with fludarabine, low-dose total body irradiation, and posttransplantation cyclophosphamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-017-1016-1

Incidence and risk factors for hemorrhagic cystitis in unmanipulated haploidentical transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-017-1016-1

Incidence and treatment strategy for disseminated adenovirus disease after haploidentical stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-017-1016-1

Epidemiology and risk factors for invasive fungal diseases in hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-017-1016-1

Hematopoetic stem cell transplantation for solid tumors in Europe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-017-1016-1

Second-line high-dose chemotherapy in patients with mediastinal and retroperitoneal primary non-seminomatous germ cell tumors: the EBMT experience

21 January 2018

1 reference

12 December 2020

Lysosomal enzyme secretion from human neutrophils mediated by cyclic CMP: inhibition of cyclic GMP accumulation and neutrophil function by glucocorticosteroids

1 reference

12 December 2020

High-dose fractionated total-body irradiation, etoposide and cyclophosphamide for treatment of malignant lymphoma: comparison of autologous bone marrow and peripheral blood stem cells

1 reference

12 December 2020

Infectious complications in cord blood and T-cell depleted haploidentical stem cell transplantation

1 reference

12 December 2020

Infectious complications in adults with bone marrow transplantation and T-cell depletion of donor marrow. Increased susceptibility to fungal infections

1 reference

12 December 2020

Long-term outcomes of HLA-haploidentical stem cell transplantation based on an FBCA conditioning regimen compared with those of HLA-identical sibling stem cell transplantation for haematologic malignancies

1 reference

12 December 2020

Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity

1 reference

12 December 2020

T-cell-replete HLA-haploidentical hematopoietic transplantation for hematologic malignancies using post-transplantation cyclophosphamide results in outcomes equivalent to those of contemporaneous HLA-matched related and unrelated donor transplantati

1 reference

12 December 2020

High-dose busulfan and cyclophosphamide followed by autologous transplantation in patients with advanced breast cancer

1 reference

12 December 2020

Busulfan, cyclophosphamide and fractionated total body irradiation for autologous or syngeneic marrow transplantation for acute and chronic myelogenous leukemia: phase I dose escalation of busulfan based on targeted plasma levels.

1 reference

12 December 2020

Letermovir for cytomegalovirus prophylaxis in hematopoietic-cell transplantation

1 reference

12 December 2020

Syngeneic marrow transplantation in patients with multiple myeloma

1 reference

12 December 2020

Graft-versus-Host Disease Prophylaxis in Unrelated Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil

1 reference

12 December 2020

The incidence and risk factors of invasive fungal infection after haploidentical haematopoietic stem cell transplantation without in vitro T-cell depletion

1 reference

12 December 2020

Effect of corticosteroids on neutrophil function: inhibition of antibody-dependent cell mediated cytotoxicity (ADCC)

1 reference

12 December 2020

Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation: donor type matters

1 reference

12 December 2020

Incidence of invasive fungal disease after unmanipulated haploidentical stem cell transplantation was significantly higher than that after HLA-matched sibling transplantation

1 reference

12 December 2020

Influence of total nucleated cell dose from marrow harvests on outcome in patients with acute myelogenous leukemia undergoing autologous transplantation

1 reference

12 December 2020

Reduced intensity stem cell transplantation for advanced soft tissue sarcomas in adults: a retrospective analysis of the European Group for Blood and Marrow Transplantation

1 reference

12 December 2020

Immune reconstitution following unmanipulated HLA-mismatched/haploidentical transplantation compared with HLA-identical sibling transplantation

1 reference

12 December 2020

Long-term follow-up of haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of leukemia: nine years of experience at a single center

1 reference

12 December 2020

Autologous transplantation with peripheral blood stem cells collected after granulocyte colony-stimulating factor in patients with acute myelogenous leukemia

1 reference

12 December 2020

Busulfan, cyclophosphamide and fractionated total body irradiation for allogeneic marrow transplantation in advanced acute and chronic myelogenous leukemia: phase I dose escalation of busulfan based on targeted plasma levels.

1 reference

12 December 2020

Preengraftment serum C-reactive protein (CRP) value may predict acute graft-versus-host disease and nonrelapse mortality after allogeneic hematopoietic stem cell transplantation

1 reference

12 December 2020

Possible implication of bacterial infection in acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

1 reference

12 December 2020

Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma

1 reference

12 December 2020

Haploidentical transplantation using T cell replete peripheral blood stem cells and myeloablative conditioning in patients with high-risk hematologic malignancies who lack conventional donors is well tolerated and produces excellent relapse-free sur

1 reference

12 December 2020

Distinct reconstitution of neutrophil functions after allogeneic peripheral blood stem cell transplantation

1 reference

12 December 2020

10.1007/S15010-017-1016-1

Identifiers

DOI

1 reference

release_zfhx6oqg3befzcvehxmfxbsxmq

10 September 2017

Fatcat ID

0 references

1 reference